New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - calcium chloride dihydrate 0.27 g;  ;  ;  ;  ; potassium chloride 0.4 g;  ;  ;  ; sodium chloride 6 g;  ;  ;  ;  ;  ; sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%);   - solution for infusion - active: calcium chloride dihydrate 0.27 g         potassium chloride 0.4 g       sodium chloride 6 g           sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%)   excipient: hydrochloric acid sodium hydroxide water for injection - compound sodium lactate (hartmann's) is used for intravenous fluid and electrolyte replacement.

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - calcium chloride dihydrate 0.2684 mg/ml; potassium chloride 0.4 mg/ml; sodium chloride 6 mg/ml; sodium lactate 3.33 mg/ml (formed in process from lactic acid + sodium hydroxide) - solution for infusion - active: calcium chloride dihydrate 0.2684 mg/ml potassium chloride 0.4 mg/ml sodium chloride 6 mg/ml sodium lactate 3.33 mg/ml (formed in process from lactic acid + sodium hydroxide) excipient: water for injection - compound sodium lactate (hartmanns) infusion solution is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. this solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - calcium chloride dihydrate 0.27 mg/ml; glucose 50 mg/ml; potassium chloride 0.4 mg/ml; sodium chloride 6 mg/ml; sodium lactate 3.22 mg/ml (lactic acid 0.0024ml/ml with sodium hydroxide 1.15mg/ml) - solution for infusion - 5 % - active: calcium chloride dihydrate 0.27 mg/ml glucose 50 mg/ml potassium chloride 0.4 mg/ml sodium chloride 6 mg/ml sodium lactate 3.22 mg/ml (lactic acid 0.0024ml/ml with sodium hydroxide 1.15mg/ml) - compound sodium lactate (hartmann's solution) and 5% dextrose iv infusion solution is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - sodium chloride, quantity: 0.45 g - injection, solution - excipient ingredients: water for injections - the solutions are indicated for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. the solutions may also be used as solvents for intravenously administered drugs where compatibility has been established. 0.9% sodium chloride injection may also be used for irrigation of wounds and moistening of wound dressings. compound sodium lactate solution is particularly suitable for the replacement of extracellular fluid loss where isotonic dehydration is evident and in burn therapy.

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at, sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - sodium chloride 0.6 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. the use of lactated ringer’s injection usp is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, lactate, or chloride could be clinically detrimental. lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

baxter healthcare pty ltd - calcium chloride; potassium chloride; sodium lactate; sodium chloride - parenteral liquid/solution/suspension - calcium chloride mineral-calcium-salt active 0.27 g/l; potassium chloride mineral-potassium active 0.4 g/l; sodium lactate mineral-sodium active 3.22 g/l; sodium chloride mineral-sodium-salt active 6.0 g/l - nutrition & metabolism - all animals - dehydration | electrolyte replacement

Ireland - English - HPRA (Health Products Regulatory Authority)

maco pharma - sodium chloride; calcium chloride dihydrate; potassium chloride; sodium lactate solution 60% - solution for infusion - 6/0.27/0.4 gram(s) - solutions affecting the electrolyte balance; electrolytes

Ireland - English - HPRA (Health Products Regulatory Authority)

carelide - sodium chloride; calcium chloride dihydrate; potassium chloride; sodium lactate solution 60% - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoire aguettant - sodium chloride; calcium chloride dihydrate; potassium chloride; sodium lactate solution 60% - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - potassium chloride; calcium chloride; sodium chloride; sodium lactate -